Contributing factors to the outcome of primary malignant chest wall tumors.

Abdel Rahman, Abdel Rahman Mohamed; Rahouma, Mohamed; Gaafar, Rabab; Bahaa, Sherif; Loay, Iman; Kamel, Mohamed; Abdelbaki, Hoda; Yahia, Maha

Abdel Rahman, Abdel Rahman Mohamed; Rahouma, Mohamed; Gaafar, Rabab; Bahaa, Sherif; Loay, Iman; Kamel, Mohamed; Abdelbaki, Hoda; Yahia, Maha.

Afiliação

Abdel Rahman ARM; Surgical Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
Rahouma M; Surgical Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
Gaafar R; Medical Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
Bahaa S; Surgical Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
Loay I; Cancer Pathology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
Kamel M; Surgical Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt.
Abdelbaki H; Radiation Therapy Department, National Cancer Institute, Cairo University, Cairo, Egypt.
Yahia M; Medical Oncology Department, National Cancer Institute, Cairo University, Cairo, Egypt.

J Thorac Dis ; 9(12): 5184-5193, 2017 Dec.

Article em En | MEDLINE | ID: mdl-29312725

Palavras-chave

Chest wall tumors; complications; estimated blood loss (EBL); local recurrence; neo-adjuvant and adjuvant treatments; reconstruction; sternal resection

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Thorac Dis Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Egito

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google